Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Martin Griffin0
Richard Jones0
Date of Patent
April 27, 2010
Patent Application Number
10344084
Date Filed
August 8, 2001
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to use of a transglutaminase in the preparation of a medicament for inhibiting angiogenesis. Preferably, the transglutaminase is a human tissue transglutaminase. Advantageously, the medicament is for treating cancer, rheumatoid arthritis, retinopathy and/or psoriasis. Additionally, the invention relates to compositions comprising a transglutaminase in an amount sufficient to inhibit angiogenesis.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
